Theriva Biologics (TOVX) Shares Outstanding (2010 - 2026)
Theriva Biologics (TOVX) posted Shares Outstanding of 45.89 million for Q2 2026, up 579.6% from 6.75 million a year earlier and up 11.7% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Shares Outstanding (2010 - 2026) Analysis & Trends
For FY2025, Theriva Biologics' Shares Outstanding came in at 12.14 million, up 800.6% from FY2024.
- Annual Shares Outstanding has increased for seven consecutive years, with a five-year compound annual growth rate of 175.8% (FY2020 to FY2025).
- In prior years, Theriva Biologics' Shares Outstanding was 1.35 million in FY2024 (+109.2%), 644,281 in FY2023 (+5.1%), 613,093 in FY2022 (+25.8%) and 487,500 in FY2021 (+541.1%).
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding in data going back to Q2 2010.
- The strongest year-over-year quarter for Shares Outstanding in the past five years was Q4 2025, with growth of 800.6%; the weakest was Q2 2023, with a decline of 4.3%.
- According to Business Quant data, Shares Outstanding for the three prior quarters was 41.07 million (Q1 2026), 12.14 million (Q4 2025) and 9.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.69 Bn | 1,140.28 Bn | 19.71 Bn | 892.40 Mn |
| 2 | Johnson & Johnson | 649.22 Bn | 569.08 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 504.17 Bn | 477.29 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 366.35 Bn | 320.73 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 303.54 Bn | 267.53 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 269.49 Bn | 243.18 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 242.61 Bn | 198.01 Bn | 7.24 Bn | 540.00 Mn |
| 8 | Gilead Sciences | 195.09 Bn | 169.29 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.48 Bn | 119.12 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Theriva Biologics | 8.77 Mn | -37.59 Mn | - | 45.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.89 Mn |
| Mar 31, 2026 | 41.07 Mn |
| Dec 31, 2025 | 12.14 Mn |
| Sep 30, 2025 | 9.68 Mn |
| Jun 30, 2025 | 6.75 Mn |
| Mar 31, 2025 | 2.78 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 775,736.00 |
| Mar 31, 2024 | 685,922.00 |
| Dec 31, 2023 | 644,281.00 |
| Sep 30, 2023 | 681,708.00 |
| Jun 30, 2023 | 606,648.00 |
| Mar 31, 2023 | 604,962.00 |
| Dec 31, 2022 | 613,093.00 |
| Sep 30, 2022 | 633,762.00 |
| Jun 30, 2022 | 633,762.00 |
| Mar 31, 2022 | 552,806.00 |
| Dec 31, 2021 | 487,500.00 |
| Sep 30, 2021 | 528,170.00 |
API Access
Theriva Biologics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();